Unity Biotechnology, Inc. Lessee, Operating Lease, Liability, to be Paid, after Year Five
Unity Biotechnology, Inc. had Lessee, Operating Lease, Liability, to be Paid, after Year Five of $5.80 million as of 2023-12-31, per its 10-K filed 2024-04-15.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive · last filed 2024-04-15
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $5.80M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $11.44M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $16.89M.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $22.18M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, after Year Five |
|---|---|
| 2023-12-31 | $5.80M 10-K · filed 2024-04-15 |
| 2022-12-31 | $11.44M 10-K · filed 2023-03-15 |
| 2021-12-31 | $16.89M 10-K · filed 2022-03-15 |
| 2020-12-31 | $22.18M 10-K · filed 2021-03-23 |
| 2020-03-31 | $27.30M 10-Q · filed 2020-05-07 |